The Medicines Co. (MDCO) Sale-Exploration Noise; Amphenol (APH) Above-Consensus Profit


Shares of The Medicines Company (Nasdaq:MDCO) surged to touch the $36.24 mark in early trade Wednesday following a report by Bloomberg indicating that the pharmaceutical giant is exploring a sale of itself

MDCO stock is trading at $32.83, up $1.32 (or +4.19%), and 4,111,892 of its shares were traded so far, a large increase in activity versus its average volume (3m) of 1,135,190

The Medicines Company, which provides medicines for patients in acute and intensive care hospitals worldwide, has 69.44M Shares Outstanding and MDCO stock 52-week range is between $25.05 and $43.79 per share



Amphenol Corp. (NYSE:APH) delivered quarterly profit and revenue numbers above Wall Street analysts’ expectations, sending its shares into positive territory on Wednesday

For the fourth quarter 2015, Amphenol posted – unaudited – sales of $1.431 billion and net income of $0.63 per diluted share, surpassing the Capital IQ Consensus Estimate of $0.59 earnings per share for the period

APH stock is currently exchanging hands for $46.33, up $0.91 (or +2.00%), and 2,003,329 shares of the company were traded so far

Amphenol, which primarily designs, manufactures, and markets electrical, electronic, and fiber optic connectors worldwide, has 308.26M Shares Outstanding and APH stock one-year range is from $44.50 to $60.54 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at